Evidence for Interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser Polymorphisms in Determining Type 2 Diabetes Intermediate Phenotypes in Overweight Subjects

 

 Buy Article Permissions and Reprints

Abstract

Background: The peroxisome proliferator-activated receptor-γ (PPARG) Pro12Ala and the PPARG co-activator-1α (PPARGC1A) Gly482Ser polymorphisms (SNPs) have been associated with type 2 diabetes mellitus (T2DM) risk. We hypothesized that independent and interactive effects of the PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms influence T2DM intermediate phenotypes.

Material and Methods: PPARG Pro12Ala and PPARGC1A Gly482Ser SNPs were studied in 680 non diabetic subjects who underwent a 75 g oral glucose tolerant test (OGTT). Glucose and insulin plasma levels in the fasting state and derived from the OGTT were included in the present study.

Results: We found significant independent effects of the PPARG and PPARGC1A variants on fasting insulin levels (p=0.02 for both), HOMA-IR (p=0.03 and p=0.02, respectively), insulin area under the curve (AUC) (p=0.007 and p=0.006, respectively) and 2-h glucose levels (p=0.02 for PPARGC1A). Furthermore, significant gene-gene interactions were found for fasting insulin, HOMA-IR and insulin AUC (p=0.03 for all). Carriers of the PPARGC1A Gly allele who were also PPARG Ala-carriers had higher fasting insulin levels (p=0.02), HOMA-IR (p=0.01) and insulin AUC (p=0.01) compared to the Ser/Ser-Ala+genotype combination, whereas no differences between the PPARGC1A genotypes among the PPARG Pro/Pro carriers were observed.

Conclusion: Together, these results showed that PPARG Pro12Ala and PPARGC1A Gly482Ser variants are associated, alone and in interaction, with insulin and glucose homeostasis and suggest that gene-gene interactions should be taken into account in candidate gene studies of T2DM to identify subjects with markedly different risks of developing the disease.

References

• 1 Altshuler D, Hirschhorn JN, Klannemark M. et al . The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.  Nat Genet. 2000;  26 76-80
  CrossrefPubMedGoogle Scholar
• 2 Ambye L, Rasmussen S, Fenger M. et al . Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome.  Diabetes Res Clin Pract. 2005;  67 175-179
  CrossrefPubMedGoogle Scholar
• 3 Andrulionyte L, Zacharova J, Chiasson JL. et al . Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.  Diabetologia. 2004;  47 2176-2184
  CrossrefPubMedGoogle Scholar
• 4 Barroso I, Luan J, Sandhu MS. et al . Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes.  Diabetologia. 2006;  49 501-505
  CrossrefPubMedGoogle Scholar
• 5 Bhat A, Koul A, Rai E. et al . PGC-1alpha Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations: a replicate case-control study.  Hum Genet. 2007;  121 609-614
  PubMedGoogle Scholar
• 6 Bosse Y, Weisnagel SJ, Bouchard C. et al . Combined effects of PPARgamma2 P12A and PPARalpha L162 V polymorphisms on glucose and insulin homeostasis: the Quebec Family Study.  J Hum Genet. 2003;  48 614-621
  CrossrefPubMedGoogle Scholar
• 7 Bouchard C. Genetic epidemiology, association and sib-pair linkage:results from the Quebec Family Study. In: Bray G, Ryan D, eds. Molecular and genetic aspects of obesity. Baton Rouge, LA, Louisiana: State University Press 1994
  Google Scholar
• 8 Chagnon YC, Borecki IB, Perusse L. et al . Genome-wide search for genes related to the fat-free body mass in the quebec family study.  Metabolism. 2000;  49 203-207
  CrossrefPubMedGoogle Scholar
• 9 Choi YS, Hong JM, Lim S. et al . Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter.  Biochem Biophys Res Commun. 2006;  344 708-712
  CrossrefPubMedGoogle Scholar
• 10 Deeb SS, Fajas L, Nemoto M. et al . A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.  Nat Genet. 1998;  20 284-287
  CrossrefPubMedGoogle Scholar
• 11 Ek J, Andersen G, Urhammer SA. et al . Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus.  Diabetologia. 2001;  44 2220-2226
  CrossrefPubMedGoogle Scholar
• 12 Franks PW, Mesa JL, Harding AH. et al . Gene-lifestyle interaction on risk of type 2 diabetes.  Nutr Metab Cardiovasc Dis. 2007;  17 104-124
  CrossrefPubMedGoogle Scholar
• 13 Freeman H, Cox RD. Type-2 diabetes: A cocktail of genetic discovery.  Hum Mol Genet. 2006;  , 15 Spec No 2 R202-R209
  CrossrefPubMedGoogle Scholar
• 14 Hara K, Tobe K, Okada T. et al . A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes.  Diabetologia. 2002;  45 740-743
  CrossrefPubMedGoogle Scholar
• 15 Hsueh WC, Cole SA, Shuldiner AR. et al . Interactions between variants in the beta3-adrenergic receptor and peroxisome proliferator-activated receptor-gamma2 genes and obesity.  Diabetes Care. 2001;  24 672-677
  CrossrefPubMedGoogle Scholar
• 16 Hu FB, Doria A, Li T. et al . Genetic variation at the adiponectin locus and risk of type 2 diabetes in women.  Diabetes. 2004;  53 209-213
  PubMedGoogle Scholar
• 17 Ioannidis JP, Ntzani EE, Trikalinos TA. et al . Replication validity of genetic association studies.  Nat Genet. 2001;  29 306-309
  CrossrefPubMedGoogle Scholar
• 18 Kunej T, Globocnik PM, Dovc P. et al . A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians.  Folia Biol (Praha). 2004;  50 157-158
  PubMedGoogle Scholar
• 19 Lacquemant C, Chikri M, Boutin P. et al . No association between the G482S polymorphism of the proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene and Type II diabetes in french caucasians.  Diabetologia. 2002;  45 602-603 , ; author reply 604
  CrossrefPubMedGoogle Scholar
• 20 Ling C, Del Guerra S, Lupi R. et al . Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion.  Diabetologia. 2008;  51 ((4)) 615-622
  CrossrefPubMedGoogle Scholar
• 21 Lohman T, Roche A, Martorell F. et al .eds Anthropometric standardization reference manual. Champaign, IL: Human Kinetics 1988
  Google Scholar
• 22 Lohmueller KE, Pearce CL, Pike M. et al . Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease.  Nat Genet. 2003;  33 177-182
  CrossrefPubMedGoogle Scholar
• 23 Masugi J, Tamori Y, Mori H. et al . Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis.  Biochem Biophys Res Commun. 2000;  268 178-182
  CrossrefPubMedGoogle Scholar
• 24 Matthews DR, Hosker JP, Rudenski AS. et al . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
  Google Scholar
• 25 Mootha VK, Lindgren CM, Eriksson KF. et al . PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.  Nat Genet. 2003;  34 267-273
  CrossrefPubMedGoogle Scholar
• 26 Mousavinasab F, Tahtinen T, Jokelainen J. et al . Common polymorphisms in the PPARgamma2 and IRS-1 genes and their interaction influence serum adiponectin concentration in young Finnish men.  Mol Genet Metab. 2005;  84 344-348
  CrossrefPubMedGoogle Scholar
• 27 Muller YL, Bogardus C, Pedersen O. et al . A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians.  Diabetes. 2003;  52 895-898
  PubMedGoogle Scholar
• 28 Nelson TL, Fingerlin TE, Moss L. et al . The peroxisome proliferator-activated receptor gamma coactivator-1 alpha gene (PGC-1alpha) is not associated with type 2 diabetes mellitus or body mass index among Hispanic and non Hispanic Whites from Colorado.  Exp Clin Endocrinol Diabetes. 2007;  115 268-275
  Article in Thieme ConnectPubMedGoogle Scholar
• 29 Nitz I, Ewert A, Klapper M. et al . Analysis of PGC-1alpha variants Gly482Ser and Thr612Met concerning their PPARgamma2-coactivation function.  Biochem Biophys Res Commun. 2007;  353 481-486
  CrossrefPubMedGoogle Scholar
• 30 Patti ME, Butte AJ, Crunkhorn S. et al . Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1.  Proc Natl Acad Sci USA. 2003;  100 8466-8471
  CrossrefPubMedGoogle Scholar
• 31 Puigserver P, Wu Z, Park CW. et al . A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis.  Cell. 1998;  92 829-839
  CrossrefPubMedGoogle Scholar
• 32 Rice T, Nadeau A, Perusse L. et al . Familial correlations in the Quebec family study: cross-trait familial resemblance for body fat with plasma glucose and insulin.  Diabetologia.. 1996;  39 1357-1364
  CrossrefPubMedGoogle Scholar
• 33 Saxena R, Voight BF, Lyssenko V. et al . Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.  Science. 2007;  316 1331-1336
  CrossrefPubMedGoogle Scholar
• 34 Scott LJ, Mohlke KL, Bonnycastle LL. et al . A genome-wide association study of type 2 diabetes in finns detects multiple susceptibility variants.  Science. 2007;  316 1341-1345
  CrossrefPubMedGoogle Scholar
• 35 Soyal S, Krempler F, Oberkofler H. et al . PGC-1alpha: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes.  Diabetologia. 2006;  49 1477-1488
  CrossrefPubMedGoogle Scholar
• 36 Stumvoll M, Stefan N, Fritsche A. et al . Interaction effect between common polymorphisms in PPARgamma2 (Pro12Ala) and insulin receptor substrate 1 (Gly972Arg) on insulin sensitivity.  J Mol Med. 2002;  80 33-38
  CrossrefPubMedGoogle Scholar
• 37 Vimaleswaran KS, Radha V, Ghosh S. et al . Peroxisome proliferator-activated receptor-gamma co-activator-1alpha (PGC-1alpha) gene polymorphisms and their relationship to Type 2 diabetes in Asian Indians.  Diabet Med. 2005;  22 1516-1521
  CrossrefPubMedGoogle Scholar
• 38 WTCCC. . Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.  Nature. 2007;  447 661-678
  CrossrefPubMedGoogle Scholar
• 39 Yang WS, Hsiung CA, Ho LT. et al . Genetic epistasis of adiponectin and PPARgamma2 genotypes in modulation of insulin sensitivity: a family-based association study.  Diabetologia. 2003;  46 977-983
  CrossrefPubMedGoogle Scholar
• 40 Zeggini E, Weedon MN, Lindgren CM. et al . Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.  Science. 2007;  316 1336-1341
  CrossrefPubMedGoogle Scholar
• 41 Zhang SL, Lu WS, Yan L. et al . Association between peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene polymorphisms and type 2 diabetes in southern Chinese population: role of altered interaction with myocyte enhancer factor 2C.  Chin Med J (Engl). 2007;  120 1878-1885
  PubMedGoogle Scholar
• 42 Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic.  Nature. 2001;  414 782-787
  CrossrefPubMedGoogle Scholar

Correspondence

L. PérussePhD 

Department of Médecine sociale et préventive

Division de Kinésiologie

PEPS – 2300 rue de la Terrasse

Université Laval

Québec, QC, G1 V 0A6

Canada

Email: Louis.Perusse@kin.msp.ulaval.ca